EPISODE · Jun 2, 2026 · 38 MIN
Optimizing HSCT in Blood Cancers
Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA Recorded on May 12, 2026 Lori Muffly, MD, MS Professor of Medicine Division of Blood and Marrow Transplantation & Cellular Therapy Stanford Medicine Stanford, CA In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next. Mentioned on this episode: www.NMDP.org www.hematology.org Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients
NOW PLAYING
Optimizing HSCT in Blood Cancers
No transcript for this episode yet
Similar Episodes
May 4, 2026 ·16m
Apr 27, 2026 ·17m
Apr 13, 2026 ·16m
Apr 6, 2026 ·16m
Mar 30, 2026 ·16m
Mar 23, 2026 ·17m